Header graphic for print
Dangerous Drugs & Medical Devices News & Commentary on Prescription Drug & Medical Device Lawsuits

2010 – Four times as many adverse cardiac events in AndroGel users vs. placebo

Posted in Androgel

In 2010, a study was published in The New England Journal of Medicine titled “Adverse events associated with testosterone administration.” by S. Basaria and a team of researchers, aiming to further clarify adverse events associated with testosterone therapy.  Currently, testosterone therapy is provided in the treatment of “Low-T” and other ailments, many in the medical field believe that testosterone is overprescribed.  Further, studies have shown that testosterone is associated with an increased risk for cardiac arrest, stroke, and death, especially in older men.

Studying a group of men older than 65 with low testosterone, Basaria administered either a placebo topical “testosterone” gel or real testosterone topical gel such as Androgel to this cohort, and closely observed the group for six months.

At the end of the observation period, 209 men remained in the study.  The research team writes “During the course of the study, the testosterone group had higher rates of cardiac, respiratory, and dermatologic events than did the placebo group. A total of 23 subjects in the testosterone group, as compared with 5 in the placebo group, had cardiovascular-related adverse events”, findings consistent with the results of other studies on the association between adverse cardiac events and testosterone therapy, but from an admittedly small sample size.

As such, the team writes “In this population of older men with limitations in mobility and a high prevalence of chronic disease, the application of a testosterone gel was associated with an increased risk of cardiovascular adverse events. The small size of the trial and the unique population prevent broader inferences from being made about the safety of testosterone therapy.”

However, the manufacturers of AndroGel (AbbVie, Inc., Abbott Laboratories, Inc.), a popular topical testosterone gel, have failed time and again to warn users of this risk.  As a result, a number of AndroGel testosterone lawsuits are currently being filed.  If you or a loved one used AndroGel and suffered an adverse cardiac event, stroke, or death as a result, you may be entitled to significant financial compensation.

For a free, no-obligation case consultation, contact our team of AndroGel lawyers at the information provided below.  We have the experience, resources, and skills required to win the justice you deserve.  Call today and see how we can help.

(855) 452 – 5529

justinian@dangerousdrugs.us

Our AndroGel Lawsuit Information page is a great place to start if you have any questions about AndroGel.